Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Ho Moon

Showing results (251-260 of 280) with videos related to

Pageof 28
Sort By:
Scientific Reports|November 19, 2020
RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemiaTaeHyung Kim, Joon Ho Moon, Jae-Sook Ahn, et al.
Experimental & Molecular Medicine|July 8, 2022
Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failureHyun Jung Hong, Kyong Hye Joung, Yong Kyung Kim, et al.
Cancer Research and Treatment|July 19, 2013
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow InvolvementByung Woog Kang, Joon Ho Moon, Yee Soo Chae, et al.
Oncotarget|January 1, 2017
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemiaJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Leukemia & Lymphoma|June 26, 2020
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysisGa-Young Song, Sung-Hoon Jung, Je-Jung Lee, et al.
Oncotarget|February 14, 2018
Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotypeJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Annals of Hematology|April 6, 2013
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemiaSang Min Lee, Won Sik Lee, Ho Jin Shin, et al.
Scientific Reports|April 12, 2024
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemiaGa-Young Song, Hyeon-Jong Kim, TaeHyung Kim, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Cardiovascular Diabetology|March 21, 2025
Metabolomic profiling reveals early biomarkers of gestational diabetes mellitus and associated hepatic steatosisYoungae Jung, Seung Mi Lee, Jinhaeng Lee, et al.
Pageof 28

Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Scientific Reports|November 19, 2020
RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemiaTaeHyung Kim, Joon Ho Moon, Jae-Sook Ahn, et al.
Experimental & Molecular Medicine|July 8, 2022
Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failureHyun Jung Hong, Kyong Hye Joung, Yong Kyung Kim, et al.
Cancer Research and Treatment|July 19, 2013
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow InvolvementByung Woog Kang, Joon Ho Moon, Yee Soo Chae, et al.
Oncotarget|January 1, 2017
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemiaJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Leukemia & Lymphoma|June 26, 2020
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysisGa-Young Song, Sung-Hoon Jung, Je-Jung Lee, et al.
Oncotarget|February 14, 2018
Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotypeJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Annals of Hematology|April 6, 2013
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemiaSang Min Lee, Won Sik Lee, Ho Jin Shin, et al.
Scientific Reports|April 12, 2024
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemiaGa-Young Song, Hyeon-Jong Kim, TaeHyung Kim, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Cardiovascular Diabetology|March 21, 2025
Metabolomic profiling reveals early biomarkers of gestational diabetes mellitus and associated hepatic steatosisYoungae Jung, Seung Mi Lee, Jinhaeng Lee, et al.
Pageof 28